user

COST-EFFECTIVENESS OF A SECONDARY PREVENTION PROGRAM IN PATIENTS WITH MYOCARDIAL INFARCTION: RESULTS FROM A RANDOMISED CONTROLLED TRIAL (PROACTIVE HEART)

被引：1
|
作者：
Turkstra, E. [1 ]
Hawkes, A. L. [2 ]
Oldenburg, B. F. [3 ]
Scuffham, P. A. [1 ]
机构：
[1] Griffith Univ, Meadowbrook, Qld 4131, Australia
[2] Canc Council Queensland, Fortitude Valley, Qld, Australia
[3] Monash Univ, Melbourne, Vic 3004, Australia
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1819
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A526 / A526
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)
    Erika Turkstra
    Anna L Hawkes
    Brian Oldenburg
    Paul A Scuffham
    BMC Cardiovascular Disorders, 13
  • [2] Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)
    Turkstra, Erika
    Hawkes, Anna L.
    Oldenburg, Brian
    Scuffham, Paul A.
    BMC CARDIOVASCULAR DISORDERS, 2013, 13
  • [3] Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients
    Hawkes, Anna L.
    Atherton, John
    Taylor, C. Barr
    Scuffham, Paul
    Eadie, Kathy
    Miller, Nancy Houston
    Oldenburg, Brian
    BMC CARDIOVASCULAR DISORDERS, 2009, 9
  • [4] Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol
    Anna L Hawkes
    John Atherton
    C Barr Taylor
    Paul Scuffham
    Kathy Eadie
    Nancy Houston Miller
    Brian Oldenburg
    BMC Cardiovascular Disorders, 9
  • [5] Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial
    Michaud, Tzeyu L.
    Wilson, Kathryn E.
    Katula, Jeffrey A.
    You, Wen
    Estabrooks, Paul A.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2023, 13 (07) : 501 - 510
  • [6] Cost-effectiveness of abciximab and stenting in acute myocardial infarction: Results from the CADILLAC trial
    Cohen, DJ
    Grines, C
    Cox, D
    Stuckey, T
    Carroll, J
    Griffin, J
    Cosgrove, RS
    Githiora, L
    Berezin, RH
    Tcheng, J
    Stone, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 31A - 31A
  • [7] Polypill for secondary prevention of myocardial infarction: Cost-effectiveness analysis in the German setting
    Barth C.
    Diekmann S.
    Neusser S.
    Bramlage P.
    Wasem J.
    Neumann A.
    Der Kardiologe, 2017, 11 (6): : 473 - 479
  • [8] EFFICACY AND COST-EFFECTIVENESS OF MALARIA PREVENTION IN PREGNANCY IN LOW AND UNSTABLE TRANSMISSION: RESULTS OF A RANDOMISED CONTROLLED TRIAL
    Ndyomugyenyi, Richard
    Clarke, Sian E.
    Hutchison, Coll
    Hansen, Kristian Schultz
    Chandramohan, Daniel
    Magnussen, Pascal
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 242 - 242
  • [9] Cost-effectiveness of pravastatin in secondary prevention in patients with myocardial infarction or instable angina in germany.: An analysis on the basis of the LIPID trial
    Szucs, TD
    Berger, K
    März, W
    Schäfer, J
    HERZ, 2000, 25 (05) : 487 - 494
  • [10] Cost-effectiveness of carvedilol in patients with left ventricular dysfunction after myocardial infarction results from the CAPRICORN trial
    Greenberg, D
    Mahoney, EM
    Caro, JJ
    Ishak, K
    Smith, GL
    Cohen, DJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 154A - 154A
12345